Screener
Pfizer PFE AOCI
AOCI at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The source filing: Pfizer’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000078003-26-000054
FAQ
- What is Pfizer's AOCI?
- Pfizer (PFE) reported AOCI of -$7.2B in Q1 2026.
- How has Pfizer's AOCI changed year-over-year?
- Pfizer's AOCI increased by 16.1% year-over-year, from -$8.58B to -$7.2B.
- What is the long-term trend for Pfizer's AOCI?
- Over 5 years (2020 to 2025), Pfizer's AOCI has grown at a 8.7% compound annual growth rate (CAGR), from -$5.31B to -$8.07B.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.
Ask your AI about Pfizer's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude